Head-to-head · free

DexCom, Inc. vs GE HealthCare

DXCM vs GEHC — return on capital, cash generation, margins and balance sheet side by side.

DXCM

6 / 8

measures where DXCM leads

GEHC

2 / 8

measures where GEHC leads

A simple count of which company scores better on each measure — not a recommendation to buy or sell.

MeasureDXCM · FY2025GEHC · FY2025
Revenue$4.7B$20.6B
Net income$836.3M$2.1B
Revenue growth (yearly, multi-year)17.5%2.7%
Free cash flow$1.1B—
Free cash flow margin23.1%—
Net cash / (debt)——
ROIC15.8%10.8%
Return on equity34.5%22.1%
Gross margin60.1%40.0%
Operating margin19.6%13.4%
Net debt / EBITDA0.28x1.65x

Figures are as reported by each company; latest fiscal year shown.

Where DexCom, Inc.'s cash went (FY2025)

Capital spending
$363.5M
Buybacks
—
Dividends
—
Acquisitions
—
Net debt issued / (repaid)
—
Full DXCM profile →

Where GE HealthCare's cash went (FY2025)

Capital spending
—
Buybacks
—
Dividends
—
Acquisitions
—
Net debt issued / (repaid)
—
Full GEHC profile →

Ask which business is stronger

"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.

Compare them free

More comparisons